Status:
UNKNOWN
A Pilot Study on HPV and Cervical Cancer Screening in Mumbai
Lead Sponsor:
Tata Memorial Hospital
Collaborating Sponsors:
University of Arizona
Conditions:
HPV Infection
Eligibility:
FEMALE
30-55 years
Phase:
NA
Brief Summary
The Study goals are to test feasibility and acceptability of point of care HPV testing with 227 women already accessing an existing cancer screening program in Mumbai, India. Describe HPV infection ty...
Detailed Description
In this pilot study, Investigators will assess the feasibility and acceptability of point of care HPV testing in an existing SVA program. There is no control group since neither the efficacy nor effec...
Eligibility Criteria
Inclusion
- Females aged 30 to 55 years (the age when screening for HPV and cervical cancer is recommended) who participate in the TMH cancer screening outreach program.
Exclusion
- Women with a known diagnosis of cancer, any other terminal diagnosis, or who are pregnant
Key Trial Info
Start Date :
April 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
May 1 2018
Estimated Enrollment :
227 Patients enrolled
Trial Details
Trial ID
NCT03229603
Start Date
April 1 2018
End Date
May 1 2018
Last Update
December 22 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tata Memorial Hospital
Mumbai, Maharashtra, India, 400012